The USA’s 340B hospital markup program is costing taxpayers an estimated $13.4 billion a year in lost Medicare rebates, ...

Los Angeles, USA-based biotech Pelage Pharmaceuticals has announced the close of a $120 million Series B financing.

Chinese biotech Xuanzhu Biopharmaceutical (2575.HK) has raised over HK$780 million ($100 million) through its debut on the ...

German biotech Tubulis has closed a 308 million euro ($361 million) series C financing, marking the largest round of its kind ...

California start-up Graph AI has raised $3 million in a seed round led by Bessemer Venture Partners, with the cash to ...

A biotech company building an AI-driven platform and autonomous laboratory systems to accelerate scientific discovery.

Merck & Co has presented additional data from Phase III studies of the investigational, once-daily, oral, two-drug regimen of ...

Shares of Omeros Corp skyrocketed 155% to $10.43 this morning, following the news of an asset purchase agreement with Novo ...

US pharma major Gilead Sciences (Nasdaq: GILD) used the European AIDS Conference in Paris to showcase progress across its HIV ...

UK-based weight loss treatment company Oxford Medical Products is targeting 2027 for the commercial release of its ...

Welcome to The Pharma Letter’s real-time coverage of the 2025 European Society of Medical Oncology (ESMO) Congress, taking ...

US biotech startup Lila Sciences has closed its series A at $350 million, lifting its total fundraising to $550 million. The ...